• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Two-stage adaptive enrichment design for testing an active factor.两阶段自适应富集设计用于检验活性因子。
J Biopharm Stat. 2020;30(1):18-30. doi: 10.1080/10543406.2019.1609015. Epub 2019 May 28.
2
Biopsychosocial influence on shoulder pain: Rationale and protocol for a pre-clinical trial.生物心理社会因素对肩部疼痛的影响:一项临床前试验的原理与方案
Contemp Clin Trials. 2017 May;56:9-17. doi: 10.1016/j.cct.2017.03.005. Epub 2017 Mar 14.
3
Mixture-based gatekeeping procedures in adaptive clinical trials.适应性临床试验中基于混合的把关程序。
J Biopharm Stat. 2018;28(1):129-145. doi: 10.1080/10543406.2017.1399901. Epub 2017 Dec 28.
4
Modified Goldilocks Design with strict type I error control in confirmatory clinical trials.确证性临床试验中具有严格Ⅰ类错误控制的改良 Goldilocks 设计。
J Biopharm Stat. 2020 Sep 2;30(5):821-833. doi: 10.1080/10543406.2020.1744620. Epub 2020 Apr 16.
5
A response adaptive design for ordinal categorical responses.用于有序分类响应的响应自适应设计。
J Biopharm Stat. 2018;28(6):1169-1181. doi: 10.1080/10543406.2018.1439053. Epub 2018 Mar 5.
6
TITE-BOIN-ET: Time-to-event Bayesian optimal interval design to accelerate dose-finding based on both efficacy and toxicity outcomes.TITE-BOIN-ET:基于疗效和毒性结局的加速剂量发现的时依贝叶斯最优区间设计。
Pharm Stat. 2020 May;19(3):335-349. doi: 10.1002/pst.1995. Epub 2019 Dec 12.
7
Statistics Commentary Series. Commentary No. 42: Minimization.统计评论系列。第42号评论:最小化。
J Clin Psychopharmacol. 2020 Sep/Oct;40(5):441-442. doi: 10.1097/JCP.0000000000001266.
8
Design optimization for dose-finding trials: a review.剂量探索试验的设计优化:综述。
J Biopharm Stat. 2020 Jul 3;30(4):662-673. doi: 10.1080/10543406.2020.1730874. Epub 2020 Mar 17.
9
Response adaptive randomization procedures in seamless phase II/III clinical trials.无缝二期/三期临床试验中的反应适应性随机化程序。
J Biopharm Stat. 2020;30(1):3-17. doi: 10.1080/10543406.2019.1657439. Epub 2019 Aug 27.
10
Flexible alpha allocation strategies for confirmatory adaptive enrichment clinical trials with a prespecified subgroup.具有预设亚组的确认性适应性富集临床试验的灵活 alpha 分配策略。
Stat Med. 2018 Oct 30;37(24):3387-3402. doi: 10.1002/sim.7851. Epub 2018 Jun 26.

本文引用的文献

1
Multiple testing procedures for adaptive enrichment designs: combining group sequential and reallocation approaches.适应性富集设计的多重检验程序:结合组序贯和重新分配方法。
Biostatistics. 2016 Oct;17(4):650-62. doi: 10.1093/biostatistics/kxw014. Epub 2016 Mar 22.
2
Twenty-five years of confirmatory adaptive designs: opportunities and pitfalls.二十五年的验证性适应性设计:机遇与陷阱。
Stat Med. 2016 Feb 10;35(3):325-47. doi: 10.1002/sim.6472. Epub 2015 Mar 16.
3
Testing for efficacy in adaptive clinical trials with enrichment.在具有富集作用的适应性临床试验中进行疗效测试。
Stat Med. 2014 Jul 20;33(16):2736-45. doi: 10.1002/sim.6127. Epub 2014 Feb 27.
4
Biopsychosocial influence on exercise-induced injury: genetic and psychological combinations are predictive of shoulder pain phenotypes.生物心理社会因素对运动损伤的影响:遗传和心理因素的组合可预测肩部疼痛表型。
J Pain. 2014 Jan;15(1):68-80. doi: 10.1016/j.jpain.2013.09.012. Epub 2013 Oct 5.
5
Adaptive enrichment designs for clinical trials.临床试验的适应性富集设计。
Biostatistics. 2013 Sep;14(4):613-25. doi: 10.1093/biostatistics/kxt010. Epub 2013 Mar 21.
6
Type I error rate control in adaptive designs for confirmatory clinical trials with treatment selection at interim.在中期进行治疗选择的确证性临床试验的适应性设计中控制I型错误率。
Pharm Stat. 2011 Mar-Apr;10(2):96-104. doi: 10.1002/pst.413.
7
Adaptive patient enrichment designs in therapeutic trials.治疗性试验中的适应性患者富集设计。
Biom J. 2009 Apr;51(2):358-74. doi: 10.1002/bimj.200900003.
8
Approaches to evaluation of treatment effect in randomized clinical trials with genomic subset.基因组亚组随机临床试验中治疗效果评估方法
Pharm Stat. 2007 Jul-Sep;6(3):227-44. doi: 10.1002/pst.300.
9
Interim treatment selection using the normal approximation approach in clinical trials.临床试验中使用正态近似法的临时治疗选择。
Stat Med. 2008 Feb 20;27(4):597-618. doi: 10.1002/sim.2990.
10
Modification of sample size in group sequential clinical trials.成组序贯临床试验中的样本量调整
Biometrics. 1999 Sep;55(3):853-7. doi: 10.1111/j.0006-341x.1999.00853.x.

两阶段自适应富集设计用于检验活性因子。

Two-stage adaptive enrichment design for testing an active factor.

机构信息

Department of Mathematics, Northeastern University, Boston, Massachusetts, USA.

Department of Biostatistics, University of Florida, Gainesville, Florida, USA.

出版信息

J Biopharm Stat. 2020;30(1):18-30. doi: 10.1080/10543406.2019.1609015. Epub 2019 May 28.

DOI:10.1080/10543406.2019.1609015
PMID:31135263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6881517/
Abstract

We propose an adaptive enrichment approach to test an active factor, which is a factor whose effect is non-zero in at least one subpopulation. We implement a two-stage play-the-winner design where all subjects in the second stage are enrolled from the subpopulation that has the highest observed effect in the first stage. We recommend a weighted Fisher's combination of the most powerful test for each stage, respectively: the first stage Hotelling's test and the second stage noncentral chi-square test. The test is further extended to cover binary outcomes and time-to-event outcomes.

摘要

我们提出了一种自适应富集方法来检验一个活跃因子,该因子在至少一个亚群中具有非零的效应。我们实施了两阶段胜者设计,其中第二阶段的所有受试者都来自第一阶段观察到效果最高的亚群。我们分别推荐了每个阶段最有力检验的加权 Fisher 组合:第一阶段的 Hotelling 检验和第二阶段的非中心卡方检验。该检验进一步扩展到涵盖二分类结局和生存时间结局。